Results 271 to 280 of about 7,340,393 (314)
Some of the next articles are maybe not open access.
Ending, Not Quite Ending, and Not Ending At All
The Psychoanalytic QuarterlyI consider the place of termination in contemporary psychoanalytic practice. A more flexible approach to therapeutic endings represents one dimension of a broader paradigm shift away from rule-boundedness and toward clinical flexibility. In any event, final, less-than-final, and absent goodbyes have always been part of psychoanalytic reality despite ...
openaire +2 more sources
Anthropological Quarterly, 2012
This paper assesses the conceptual and technological negotiation of an absolute end. The idea of a total ending is sublime: it is located outside of language and powerful precisely because of its sheer incomprehensibility. Yet, through the 20th century the United States built large-scale technological systems capable of achieving an absolute end to
openaire +1 more source
This paper assesses the conceptual and technological negotiation of an absolute end. The idea of a total ending is sublime: it is located outside of language and powerful precisely because of its sheer incomprehensibility. Yet, through the 20th century the United States built large-scale technological systems capable of achieving an absolute end to
openaire +1 more source
On Terminating, Ending, and Not Ending
The Psychoanalytic QuarterlyThe author describes and reflects upon his clinical experiences with both mutually desired terminations and coerced endings. He addresses issues of technique, being real in termination and post-termination contact in addition to offering his perspectives on the role of theory in determining the phenomena of termination, retraumatizing aspects of ...
openaire +2 more sources
Chemical & Engineering News Archive, 2014
In 2009, when Lonza made a bid to acquire Patheon, a contract manufacturer of drugs in final dosage form, industry watchers shook their heads and said, “Nope.” Such an acquisition didn’t make sense, given the fundamental differences between Lonza’s main business, the manufacture of active pharmaceutical ingredients (APIs), and Patheon’s production of ...
openaire +1 more source
In 2009, when Lonza made a bid to acquire Patheon, a contract manufacturer of drugs in final dosage form, industry watchers shook their heads and said, “Nope.” Such an acquisition didn’t make sense, given the fundamental differences between Lonza’s main business, the manufacture of active pharmaceutical ingredients (APIs), and Patheon’s production of ...
openaire +1 more source
HEALING OF END‐IN‐END ANASTOMOSES
Australian and New Zealand Journal of Surgery, 1960Summary An account is given of the series of changes observed in the healing of an end‐in‐end anastomosis constructed in the rates ileum. It was found that mucosal continuity was re‐established mainly by the contraction of newly formed granulation tissue on the peritoneal surface of the intussuscepted bowel.
openaire +2 more sources
The End of the Classical: The End of the Beginning, the End of the End
Perspecta, 1984openaire +1 more source
Mechanism, cellular functions and cancer roles of polymerase-theta-mediated DNA end joining
Nature Reviews Molecular Cell Biology, 2021Dale A Ramsden +2 more
exaly